VisEn lands $5M in venture capital financing round

TriMed Staff | | Health Imaging | Diagnostic Imaging

VisEn Medical, a medical imaging technology company, has closed a $5 million tranche of Series B financing.

Merck Capital Ventures and Flagship Ventures co-led the expansion of the venture capital (VC) round, which initially raised $7 million in November 2007, bringing the total VC financing round to $12 million.

The Woburn, Mass.-based VisEn said it would use the additional financing to further advance its proprietary fluorescence in vivo imaging product pipelines, and to expand its commercial applications.

VisEn was initially founded in 2000 based on fluorescence in vivo imaging technologies developed at Massachusetts General Hospital and Harvard Medical School; both located in Boston.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.